电场治疗神经胶质瘤的研究进展

doi:10.3760/cma.j.issn.1673-422X.2017.06.016

国际肿瘤学杂志 ›› 2017, Vol. 44 ›› Issue (6): 464-.doi: 10.3760/cma.j.issn.1673-422X.2017.06.016

电场治疗神经胶质瘤的研究进展

毛昀，李利亚

100029 北京中医药大学研究生院（毛昀）；中日友好医院中西医结合肿瘤科（毛昀、李利亚）

出版日期:2017-06-08 发布日期:2017-06-16
通讯作者: 李利亚 E-mail:li.liya2007@163.com
基金资助:
国家自然科学基金（81372412）

Research progress of electric field in the treatment of glioma

Mao Yun, Li Liya

Graduate School of Beijing University of Chinese Medicine; Department of Integrated Traditional Chinese and Western Medicine Oncology, ChinaJapan Friendship Hospital, Beijing 100029, China

Online:2017-06-08 Published:2017-06-16
Contact: Li Liya E-mail:li.liya2007@163.com
Supported by:
National Natural Science Foundation of China (81372412)

摘要/Abstract

摘要： 电场治疗肿瘤技术在神经胶质瘤的治疗中具有重要意义，其包括直流电场和交流电场。直流电场影响胶质瘤细胞的迁移，可作为治疗胶质瘤的新线索；交流电场能抑制胶质瘤细胞的增殖、侵袭并诱导凋亡，明显延长胶质瘤患者生存期及提高患者生命质量。

关键词: 神经胶质瘤, 电磁场, 中频交变电场

Abstract: Electric field treatment of tumor technology is of great significance in the treatment of glioma, including direct current electric field and alternating electric field. Direct current electric field affects the migration of glioma cells, and can be used as a new clue for the treatment of glioma. While alternating electric field can inhibit the proliferation and invasion of glioma cells, and induce apoptosis, and can obviously prolong the survival period of patients with glioma and improve their quality of life.

Key words: Glioma, Electromagnetic fields, Intermediate frequency alternating electric field

毛昀，李利亚. 电场治疗神经胶质瘤的研究进展[J]. 国际肿瘤学杂志, 2017, 44(6): 464-.

Mao Yun, Li Liya. Research progress of electric field in the treatment of glioma[J]. Journal of International Oncology, 2017, 44(6): 464-.

参考文献

［1］ Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review［J］. JAMA, 2013, 310(17): 1842-1850. DOI: 10.1001/jama.2013.280319. ［2］ Liu Y, Yan W, Zhang W, et al. MiR218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1［J］. Oncol Rep, 2012, 28(3): 1013-1021. DOI: 10.3892/or.2012.1902. ［3］ Griffin M, Iqbal SA, Sebastian A, et al. Degenerate wave and capacitive coupling increase human MSC invasion and proliferation while reducing cytotoxicity in an in vitro wound healing model［J］. PLoS One, 2011, 6 (8): e23404. DOI: 10.1371/journal.pone.0023404. ［4］ Creecy CM, O′neill CF, Arulanandam BP, et al. Mesenchymal stem cell osteodifferentiation in response to alternating electric current［J］. Tissue Eng Part A, 2013, 19(34): 467-474. DOI: 10.1089/ten.tea.2012.0091. ［5］ Zhao Z, Watt C, Karystinou A, et al. Directed migration of human bone marrow mesenchymal stem cells in a physiological direct current electric field［J］. Eur Cell Mater, 2011, 22: 344-358. ［6］ Yamashita M. Fluctuations in nuclear envelope′s potential mediate synchronization of early neural activity［J］. Biochem Biophys Res Commun, 2011, 406(1): 107-111. DOI: 10.1016/j.bbrc.2011.02.004. ［7］ Cuzick J, Holland R, Barth V, et al. Electropotential measurements as a new diagnostic modality for breast cancer［J］. Lancet, 1998, 352 (9125): 359-363. ［8］ Mycielska ME, Djamgoz MB. Cellular mechanisms of directcurrent electric field effects: galvanotaxis and metastatic disease［J］. J Cell Sci, 2004, 117 (Pt 9): 1631-1639. ［9］ Cao L, Wei D, Reid B, et al. Endogenous electric currents might guide rostral migration of neuroblasts［J］. EMBO Rep, 2013, 14(2): 184-190. DOI: 10.1038/embor.2012.215. ［10］ Cuddapah VA, Robel S, Watkins S, et al. A neurocentric perspective on glioma invasion［J］. Nat Rev Neurosci, 2014, 15(7): 455-465. DOI: 10.1038/nrn3765. ［11］李飞. 脑胶质瘤侵袭生长的相关因素及直流电场诱导U87胶质瘤细胞定向迁移［D］. 重庆: 第三军医大学, 2011. ［12］ Li F, Chen T, Hu S, et al. Superoxide mediates direct current electric fieldinduced directional migration of glioma cells through the activation of AKT and ERK［J］. PLoS One, 2013, 8(4): e61195. DOI: 10.1371/journal.pone.0061195. ［13］ Huang YJ, Hoffmann G, Wheeler B, et al. Cellular microenvironment modulates the galvanotaxis of brain tumor initiating cells［J］. Sci Rep, 2016, 6: 21583. DOI: 10.1038/srep21583. ［14］ Wu S, Wang Y, Guo J, et al. Nanosecond pulsed electric fields as a novel drug free therapy for breast cancer: an in vivo study［J］. Cancer Lett, 2014, 343(2): 268-274. DOI: 10.1016/j.canlet.2013.09.032. ［15］ Guo F, Yao C, Li C, et al. In vivo evidences of nanosecond pulsed electric fields for melanoma malignancy treatment on tumorbearing BALB/c nude mice［J］. Technol Cancer Res Treat, 2014, 13(4): 337-344. DOI: 10.7785/tcrt.2012.500385. ［16］ Kirson ED, Gurvich Z, Schneiderman R, et al. Disruption of cancer cell replication by alternating electric fields［J］. Cancer Res, 2004, 64(9): 3288-3295. DOI: 10.1158/00085472. ［17］ Gutin PH, Wong ET. Noninvasive application of alternating electric fields in glioblastoma: a fourth cancer treatment modality［J］. Am Soc Clin Oncol Educ Book, 2012, 32: 126-131. DOI: 10.14694/EdBook_AM.2012.32.126. ［18］ Gera N, Yang A, Holtzman TS, et al. Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit［J］. PLoS One, 2015, 10(5): e0125269. DOI: 10.1371/journal.pone.0125269. ［19］ Kim EH, Song HS, Yoo SH, et al. Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis［J］. Oncotarget, 2016, 7(40): 65125-65136. DOI: 10.18632/oncotarget.11372. ［20］ Kirson ED, Dbal V, Tovarys F, et al. Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors［J］. Proc Nat Acad Sci USA, 2007, 104(24): 10152-10157. DOI: 10.1073/pnas.0702916104. ［21］ Wenger C, Salvador R, Basser PJ, et al. The electric field distribution in the brain during TTFields therapy and its dependence on tissue dielectric properties and anatomy: a computational study［J］. Phys Med Biol, 2015, 60(18): 7339-7357. DOI: 10.1088/00319155/60/18/7339. ［22］ Stupp R, Wong ET, Kanner AA, et al. NovoTTF100A versus physician′s choice chemotherapy in recurrent glioblastoma: a randomised phase Ⅲ trial of a novel treatment modality［J］. Eur J Cancer, 2012, 48(14): 2192-2202. DOI: 10.1016/j.ejca.2012.04.011. ［23］ Stupp R, Taillibert S , Kanner AA, et al. Maintenance therapy with tumortreating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial［J］. JAMA, 2015, 314 (23): 2535-2543. DOI: 10.1001/jama.2015.16669. ［24］ Ansstas G, Tran DD. Treatment with tumortreating fields therapy and pulse dose bevacizumab in patients with bevacizumabrefractory recurrent glioblastoma: a case series［J］. Case Rep Neurol, 2016, 8(1): 1-9. DOI: 10.1159/000442196. ［25］ Wong ET, Lok E, Swanson KD. Clinical benefit in recurrent glioblastoma from adjuvant NovoTTF100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation［J］. Cancer Med, 2015, 4(3): 383-391. DOI: 10.1002/cam4.421. ［26］ Fonkem E, Wong ET. NovoTTF100A: a new treatment modality for recurrent glioblastoma［J］. Expert Rev Neurother, 2012, 12(8): 895-899. ［27］ Turner SG, Gergel T, Wu H, et al. The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTFTM100A system［J］. World J Surg Oncol, 2014, 12: 162. DOI: 10.1186/1477781912162.

[1]	刘萍萍, 何学芳, 张翼, 杨旭, 张珊珊, 季一飞. 原发性脑胶质瘤患者术后复发危险因素及预测模型构建[J]. 国际肿瘤学杂志, 2024, 51(4): 193-197.
[2]	肖楠, 孙鹏飞. 氧化应激在胶质瘤放化疗敏感性中的研究进展[J]. 国际肿瘤学杂志, 2022, 49(6): 357-361.
[3]	孔春禹, 孙鹏飞. SLC7A11与胶质瘤[J]. 国际肿瘤学杂志, 2022, 49(10): 604-607.
[4]	郭世豪, 任叶青, 郭庚. 脑胶质瘤血管生成拟态分子机制[J]. 国际肿瘤学杂志, 2021, 48(6): 362-365.
[5]	王宪伟, 史美燕, 王凤芹, 齐福, 王朝喆, 周飞. TSA上调miR-4298靶向抑制PADI4表达在诱导U251细胞凋亡中的作用[J]. 国际肿瘤学杂志, 2021, 48(4): 193-199.
[6]	张雯, 胡伟国, 宋启斌. 3D-ASL与DCE-MRI在脑胶质瘤复发与放射性脑坏死鉴别诊断中的价值[J]. 国际肿瘤学杂志, 2021, 48(10): 631-634.
[7]	赵聪选, 于韬. 胶质瘤相关基因的挖掘及预测[J]. 国际肿瘤学杂志, 2020, 47(5): 293-296.
[8]	南阳, 钟跃. 长非编码RNA在神经胶质瘤研究中的新进展[J]. 国际肿瘤学杂志, 2020, 47(2): 98-102.
[9]	张雯, 宋启斌, 胡伟国. 多模态磁共振成像在脑胶质瘤中的临床应用[J]. 国际肿瘤学杂志, 2020, 47(11): 686-690.
[10]	陈亮, 秦军, 雷军荣, 刘俊, 王璐. miR-1254通过靶向CSF-1抑制胶质瘤细胞的增殖和侵袭能力[J]. 国际肿瘤学杂志, 2020, 47(10): 577-584.
[11]	张千慧, 张洋, 宿伟鹏, 张宋安, 刘攀, 赵化荣. LSD1、MGMT和Ki-67在高级别胶质瘤中的表达及对预后的影响[J]. 国际肿瘤学杂志, 2019, 46(9): 519-525.
[12]	衣琳, 邱实. 紫草素抗胶质瘤效应及其作用机制[J]. 国际肿瘤学杂志, 2019, 46(8): 489-491.
[13]	于学娟, 安宏伟, 孙亚梅, 姜政, 张学海, 杨文敬, 张伟. MMP2、TIMP2、Ki-67、P53在胶质瘤组织中的表达及意义 [J]. 国际肿瘤学杂志, 2019, 46(12): 718-722.
[14]	卢迪,张钧栋,郭庚,王小刚. 干扰素通路中的关键分子诱导脑胶质瘤细胞凋亡的机制[J]. 国际肿瘤学杂志, 2018, 45(7): 432-435.
[15]	张园园，朱淑霞. 微小RNA-495在神经胶质瘤中的作用机制[J]. 国际肿瘤学杂志, 2018, 45(6): 362-364.

电场治疗神经胶质瘤的研究进展

Research progress of electric field in the treatment of glioma

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价